“I got an ultrasound, and it showed a solid mass.” Follow-up tests revealed Towle had bile duct cancer, also called ...

Tests and ultrasounds at the time of her hospital trip revealed multiple lesions on her liver, and biopsies showed she had stage 4 cholangiocarcinoma, otherwise known as a rare bile duct cancer. Back ...

Lisata Therapeutics Inc (LSTA) reports effective cost management and promising clinical developments, despite challenges in ...

The Bismuth–Corlette classification system provides an anatomic description of the tumor location and longitudinal extension in the biliary tree (Figure 3). It is limited due to its failure to ...

The family of a young Kitchener woman, who died Sunday from a rare bile duct cancer, is promising her quest to get provincial funding for a drug that helped extend her life will continue.

Analysts have set 12-month price targets for Incyte, revealing an average target of $73.69, a high estimate of $97.00, and a ...

Between 1990 and 2019, cases of cancer in young people across the globe have increased by 79 percent and deaths have risen 28 ...

“This is a strategy to be able to do that.” Treatments for cancers like PDAC that could be derived from this study include ...

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision ...

CENDIFOX: Phase 1b/2a open-label trial in the U.S. of certepetide in combination with neoadjuvant FOLFIRINOX based therapies in pancreatic, colon and appendiceal cancers. The trial has completed ...

Learn how personalised treatments are providing new hope with tailored therapies offering better outcomes for patients ...